ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 232 filers reported holding ZAI LAB LTD in Q2 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $673,282 | +8.3% | 20,243 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $621,460 | -34.2% | 20,243 | -26.7% | 0.00% | -50.0% |
| Q3 2022 | $944,000 | -1.5% | 27,616 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $958,000 | -21.2% | 27,616 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,215,000 | -30.0% | 27,616 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $1,736,000 | -40.3% | 27,616 | 0.0% | 0.01% | -44.4% |
| Q3 2021 | $2,910,000 | -40.5% | 27,616 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $4,888,000 | +32.6% | 27,616 | 0.0% | 0.02% | +23.1% |
| Q1 2021 | $3,685,000 | +34.8% | 27,616 | +36.8% | 0.01% | +30.0% |
| Q4 2020 | $2,733,000 | +62.7% | 20,194 | 0.0% | 0.01% | +42.9% |
| Q3 2020 | $1,680,000 | +1.3% | 20,194 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,659,000 | +59.5% | 20,194 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $1,040,000 | – | 20,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
| Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
| INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
| HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
| EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
| Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
| Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
| Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |